CEREVEL THERAPEUTICS HOLDINGS, INC.

(CERE)
  Report
Delayed Nasdaq  -  05/13 04:00:01 pm EDT
23.90 USD   +9.83%
05/11Berenberg Bank Adjusts Cerevel Therapeutics Holdings Price Target to $44 From $46, Maintains Buy Rating
MT
05/10Cerevel Therapeutics Q1 Loss Widens
MT
05/10CEREVEL THERAPEUTICS HOLDINGS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Upcoming event on CEREVEL THERAPEUTICS HOLDINGS, INC.